Nutex Health Inc. (NUTX)
NASDAQ: NUTXConsumer DiscretionaryBusiness ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NUTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.12B
- P/E (TTM)
- 7.04
- Forward P/E
- 8.00
- EPS (TTM)
- $23.11
- Dividend yield
- None
- Ex-dividend date
- Nov 30, 2026
- 52-week range
- 83.99 – 226.16
- Day range
- 155.04 – 165.14
- Volume / Avg
- 157.52K / 149.94K
- Beta
- —
- Shares outstanding
- 6.86M
52-week range
NUTX stock today
On Nov 20, NUTX ended the session at $162.64, adding $0.54 (0.33%), versus the S&P 500's 3.70% decline. Shares are 28.1% below their 52-week high of $226.16, set on Oct 6, 2026 and 93.6% above the 52-week low of $83.99, in the middle of the past year's range. NUTX is down 1.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 18.8%.
At 7.0x trailing earnings, Nutex Health trades below the peer-group median of 31.2x. Its forward P/E of 8.0x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. To receive the next $2.00 dividend, investors must own shares before the Nov 30 ex-dividend date.
Summary generated from market data by MetaCap's automated system. Methodology
About Nutex Health
Company profileNutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate.
- Sector
- Consumer Discretionary
- Industry
- Business Services
- CEO
- Dr. Thomas T. Vo M.B.A., M.D.
- Headquarters
- Houston, TX
- Employees
- 1,093
- Website
- nutexhealth.com
Financial highlights
Full financialsIn fiscal 2025, Nutex Health generated $875.3 million in revenue, up 82.4% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $70.8 million (+35.9% year over year), for a net margin of 8.1% versus a median of 10.9% in the prior 5 years. Gross margin was 50.8% (up from 40.9%) and operating margin 31.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $875.26M | $479.95M | $247.65M | $219.29M | $331.53M |
| Growth | +82.36% | +93.80% | +12.93% | -33.85% | +20.98% |
| Net income | $70.79M | $52.10M | $-45.79M | $-424.78M | $132.59M |
| EPS (diluted) | $10.48 | $9.69 | $-10.39 | $-100.36 | $0.22 |
Analyst forecast
ForecastConsensus (6 analysts)
strong_buy
Avg. price target
$313.67+92.86%
- Strong buy 1
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $5.71 vs $5.53
- Surprise
- +3.25%
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $2.00
- Ex-dividend date
- Nov 30, 2026
- Pay date
- Dec 14, 2026
NUTX news
All NUTX news- Nutex Health Declares First Cash Dividend Of $2 Per Share Following Q3 ResultsNasdaqNUTX, HEI.A
- Nutex Health announces $2 special dividend, its first as public companySeeking Alpha
- Nutex Health Declares First Dividend as a Public CompanyPR Newswire
- Nutex Health Named a 2026 Houston Top Workplace by Houston ChroniclePR Newswire
- Nutex Health (NUTX) Q3 2026 Earnings Call TranscriptNasdaq
- Nutex Health Inc. Reports Third Quarter 2026 Net Income of $40.2 millionNasdaq
- Nutex Health GAAP EPS of $5.71 beats by $0.17, revenue of $217.6M beats by $2.78MSeeking Alpha
- NUTEX HEALTH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTSPR Newswire
Nutex Health peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ANDGAndersen Group Inc. Class A | 57.85 | +0.40% | $1.14B | vs NUTX |
| AHGAkso Health Group ADS | 1.26 | -1.56% | $1.08B | vs NUTX |
| QNSTQuinStreet Inc. | 18.49 | -2.74% | $1.06B | vs NUTX |
| LQDTLiquidity Services Inc. | 31.87 | -3.51% | $1.00B | vs NUTX |
| RSKDRiskified Ltd. Class A | 9.46 | -1.77% | $1.26B | vs NUTX |
| RDWRRadware Ltd. | 32.22 | -4.50% | $1.36B | vs NUTX |
| MAXMediaAlpha Inc. Class A | 13.50 | -2.46% | $784.00M | vs NUTX |
| PHRPhreesia Inc. | 11.41 | -3.88% | $708.23M | vs NUTX |
Indexes, lists and sector
Nutex Health stock FAQ
What is Nutex Health's stock price today?
NUTX last traded at $162.64 as of Nov 20, 4:00 PM EST, up 0.33% on the day. Prices are delayed at least 15 minutes.
Does Nutex Health pay a dividend?
Yes. Nutex Health pays $0.00 per share annually. The most recent dividend of $2.00 had an ex-dividend date of Nov 30, 2026.
What is NUTX's P/E ratio?
NUTX trades at a trailing P/E ratio of 7.04 and a forward P/E of 8.00, compared with a median of 31.2 for its closest peers.
Who is Nutex Health's CEO?
Dr. Thomas T. Vo M.B.A., M.D. is the chief executive officer of Nutex Health Inc., which has about 1,093 employees.
Has NUTX ever split its stock?
Yes. The most recent NUTX stock split was a 1-for-10 split on Jul 3, 2024, one of 2 splits on record.
What is the NUTX 52-week high?
The 52-week high for NUTX is $226.16 and the 52-week low is $83.99. The stock is currently 28.1% below its high.